DAFNA Capital Management LLC - CTI BIOPHARMA CORP ownership

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2015$3,930,000
+16.9%
3,195,381
+124.2%
3.50%
+31.7%
Q4 2014$3,363,0001,425,0002.66%
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q3 2023.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders